| 1 |
34592918 | New horizons in the roles and associations of COX-2 and novel natural inhibitors in cardiovascular diseases. | 2021 Sep 30 |
1 |
| 2 |
31000626 | Fluorescent indomethacin-dansyl conjugates utilize the membrane-binding domain of cyclooxygenase-2 to block the opening to the active site. | 2019 May 31 |
3 |
| 3 |
26704937 | Conservative Secondary Shell Substitution In Cyclooxygenase-2 Reduces Inhibition by Indomethacin Amides and Esters via Altered Enzyme Dynamics. | 2016 Jan 19 |
1 |
| 4 |
27229194 | A Series of COX-2 Inhibitors Endowed with NO-Releasing Properties: Synthesis, Biological Evaluation, and Docking Analysis. | 2016 Aug 19 |
4 |
| 5 |
25596758 | Synthesis, biological evaluation and docking analysis of a new series of methylsulfonyl and sulfamoyl acetamides and ethyl acetates as potent COX-2 inhibitors. | 2015 Feb 15 |
2 |
| 6 |
26392530 | Competition and allostery govern substrate selectivity of cyclooxygenase-2. | 2015 Oct 6 |
2 |
| 7 |
24660685 | Novel dual inhibitors of nuclear factor-kappa B (NF-κB) and cyclooxygenase- 2 (COX-2): synthesis, in vitro anticancer activity and stability studies of lantadene-non steroidal anti-inflammatory drug (NSAID) conjugates. | 2014 |
1 |
| 8 |
17764958 | Novel (E)-2-(aryl)-3-(4-methanesulfonylphenyl)acrylic ester prodrugs possessing a diazen-1-ium-1,2-diolate moiety: design, synthesis, cyclooxygenase inhibition, and nitric oxide release studies. | 2007 Nov 1 |
2 |
| 9 |
15857149 | 1,5-Diarylpyrrole-3-acetic acids and esters as novel classes of potent and highly selective cyclooxygenase-2 inhibitors. | 2005 May 5 |
1 |
| 10 |
12086537 | Combined MEDV-GA-MLR method for QSAR of three panels of steroids, dipeptides, and COX-2 inhibitors. | 2002 May-Jun |
1 |
| 11 |
12135387 | Isoform-selective interaction of cyclooxygenase-2 with indomethacin amides studied by real-time fluorescence, inhibition kinetics, and site-directed mutagenesis. | 2002 Jul 30 |
2 |
| 12 |
10956194 | Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors. | 2000 Jul 27 |
2 |